Rapid proteomic analysis for solid tumors reveals LSD1 as a drug target in an end-stage cancer patient

Recent advances in mass spectrometry (MS)-based technologies are now set to transform translational cancer proteomics from an idea to a practice. Here, we present a robust proteomic workflow for the analysis of clinically relevant human cancer tissues that allows quantitation of thousands of tumor p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Doll, Sophia (VerfasserIn) , Kriegmair, Maximilian (VerfasserIn) , Porubský, Štefan (VerfasserIn) , Nuhn, Philipp (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 14 June 2018
In: Molecular oncology
Year: 2018, Jahrgang: 12, Heft: 8, Pages: 1296-1307
ISSN:1878-0261
DOI:10.1002/1878-0261.12326
Online-Zugang:Verlag, Volltext: https://doi.org/10.1002/1878-0261.12326
Verlag, Volltext: https://febs.onlinelibrary.wiley.com/doi/abs/10.1002/1878-0261.12326
Volltext
Verfasserangaben:Sophia Doll, Maximilian C. Kriegmair, Alberto Santos, Michael Wierer, Fabian Coscia, Helen Michele Neil, Stefan Porubsky, Philipp E. Geyer, Andreas Mund, Philipp Nuhn and Matthias Mann

MARC

LEADER 00000caa a2200000 c 4500
001 1663081689
003 DE-627
005 20230426154305.0
007 cr uuu---uuuuu
008 190410s2018 xx |||||o 00| ||eng c
024 7 |a 10.1002/1878-0261.12326  |2 doi 
035 |a (DE-627)1663081689 
035 |a (DE-599)KXP1663081689 
035 |a (OCoLC)1341208114 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Doll, Sophia  |e VerfasserIn  |0 (DE-588)1183166273  |0 (DE-627)1663083274  |4 aut 
245 1 0 |a Rapid proteomic analysis for solid tumors reveals LSD1 as a drug target in an end-stage cancer patient  |c Sophia Doll, Maximilian C. Kriegmair, Alberto Santos, Michael Wierer, Fabian Coscia, Helen Michele Neil, Stefan Porubsky, Philipp E. Geyer, Andreas Mund, Philipp Nuhn and Matthias Mann 
264 1 |c 14 June 2018 
300 |a 12 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 10.04.2019 
520 |a Recent advances in mass spectrometry (MS)-based technologies are now set to transform translational cancer proteomics from an idea to a practice. Here, we present a robust proteomic workflow for the analysis of clinically relevant human cancer tissues that allows quantitation of thousands of tumor proteins in several hours of measuring time and a total turnaround of a few days. We applied it to a chemorefractory metastatic case of the extremely rare urachal carcinoma. Quantitative comparison of lung metastases and surrounding tissue revealed several significantly upregulated proteins, among them lysine-specific histone demethylase 1 (LSD1/KDM1A). LSD1 is an epigenetic regulator and the target of active development efforts in oncology. Thus, clinical cancer proteomics can rapidly and efficiently identify actionable therapeutic options. While currently described for a single case study, we envision that it can be applied broadly to other patients in a similar condition. 
650 4 |a case study 
650 4 |a clinical proteomics 
650 4 |a epigenetics 
650 4 |a mass spectrometry 
650 4 |a urachal carcinoma 
700 1 |a Kriegmair, Maximilian  |d 1987-  |e VerfasserIn  |0 (DE-588)1049742745  |0 (DE-627)782573347  |0 (DE-576)403726840  |4 aut 
700 1 |a Porubský, Štefan  |d 1977-  |e VerfasserIn  |0 (DE-588)12958844X  |0 (DE-627)473362341  |0 (DE-576)29773637X  |4 aut 
700 1 |a Nuhn, Philipp  |d 1981-  |e VerfasserIn  |0 (DE-588)136112951  |0 (DE-627)694090808  |0 (DE-576)30083909X  |4 aut 
773 0 8 |i Enthalten in  |t Molecular oncology  |d Hoboken, NJ : John Wiley & Sons, Inc., 2007  |g 12(2018), 8, Seite 1296-1307  |h Online-Ressource  |w (DE-627)531199800  |w (DE-600)2322586-5  |w (DE-576)271586621  |x 1878-0261  |7 nnas  |a Rapid proteomic analysis for solid tumors reveals LSD1 as a drug target in an end-stage cancer patient 
773 1 8 |g volume:12  |g year:2018  |g number:8  |g pages:1296-1307  |g extent:12  |a Rapid proteomic analysis for solid tumors reveals LSD1 as a drug target in an end-stage cancer patient 
856 4 0 |u https://doi.org/10.1002/1878-0261.12326  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://febs.onlinelibrary.wiley.com/doi/abs/10.1002/1878-0261.12326  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20190410 
993 |a Article 
994 |a 2018 
998 |g 136112951  |a Nuhn, Philipp  |m 136112951:Nuhn, Philipp  |d 60000  |d 63100  |e 60000PN136112951  |e 63100PN136112951  |k 0/60000/  |k 1/60000/63100/  |p 10 
998 |g 12958844X  |a Porubský, Štefan  |m 12958844X:Porubský, Štefan  |d 60000  |d 63400  |e 60000PP12958844X  |e 63400PP12958844X  |k 0/60000/  |k 1/60000/63400/  |p 7 
998 |g 1049742745  |a Kriegmair, Maximilian  |m 1049742745:Kriegmair, Maximilian  |d 60000  |d 63100  |e 60000PK1049742745  |e 63100PK1049742745  |k 0/60000/  |k 1/60000/63100/  |p 2 
999 |a KXP-PPN1663081689  |e 3421299471 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Sophia Doll, Maximilian C. Kriegmair, Alberto Santos, Michael Wierer, Fabian Coscia, Helen Michele Neil, Stefan Porubsky, Philipp E. Geyer, Andreas Mund, Philipp Nuhn and Matthias Mann"]},"person":[{"display":"Doll, Sophia","given":"Sophia","role":"aut","family":"Doll"},{"family":"Kriegmair","display":"Kriegmair, Maximilian","given":"Maximilian","role":"aut"},{"given":"Štefan","role":"aut","display":"Porubský, Štefan","family":"Porubský"},{"family":"Nuhn","display":"Nuhn, Philipp","given":"Philipp","role":"aut"}],"recId":"1663081689","origin":[{"dateIssuedKey":"2018","dateIssuedDisp":"14 June 2018"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"doi":["10.1002/1878-0261.12326"],"eki":["1663081689"]},"physDesc":[{"extent":"12 S."}],"note":["Gesehen am 10.04.2019"],"relHost":[{"pubHistory":["1.2007 -"],"title":[{"title_sort":"Molecular oncology","title":"Molecular oncology"}],"part":{"volume":"12","year":"2018","text":"12(2018), 8, Seite 1296-1307","issue":"8","pages":"1296-1307","extent":"12"},"language":["eng"],"recId":"531199800","origin":[{"dateIssuedKey":"2007","publisher":"John Wiley & Sons, Inc. ; Elsevier","dateIssuedDisp":"2007-","publisherPlace":"Hoboken, NJ ; Amsterdam [u.a.]"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Rapid proteomic analysis for solid tumors reveals LSD1 as a drug target in an end-stage cancer patientMolecular oncology","id":{"zdb":["2322586-5"],"issn":["1878-0261"],"eki":["531199800"]},"physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 25.06.20"],"name":{"displayForm":["Federation of European Biochemical Societies"]}}],"title":[{"title_sort":"Rapid proteomic analysis for solid tumors reveals LSD1 as a drug target in an end-stage cancer patient","title":"Rapid proteomic analysis for solid tumors reveals LSD1 as a drug target in an end-stage cancer patient"}],"language":["eng"]} 
SRT |a DOLLSOPHIARAPIDPROTE1420